Cleared Traditional

K895569 - VALPROIC ACID (FPIA) KIT

K895569 is an FDA 510(k) clearance for VALPROIC ACID (FPIA) KIT, manufactured by Tudor Laboratories, Inc.. The device is a Class 2 Toxicology device with product code LEG cleared through the Traditional 510(k) pathway after a 27-day FDA review.

K895569 · Tudor Laboratories, Inc. · Toxicology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1989
Decision
27d
Days
Class 2
Risk

K895569 is an FDA 510(k) clearance for the VALPROIC ACID (FPIA) KIT. Classified as Enzyme Immunoassay, Valproic Acid (product code LEG), Class II - Special Controls.

Submitted by Tudor Laboratories, Inc. (Dallas, US). The FDA issued a Cleared decision on October 3, 1989 after a review of 27 days - a notably fast clearance cycle.

This device falls under the Toxicology FDA review panel, regulated under 21 CFR 862.3645 - the FDA toxicology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Tudor Laboratories, Inc. devices

FDA 510(k) Submission Details - K895569

510(k) Number K895569 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 06, 1989
Decision Date October 03, 1989
Days to Decision 27 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
60d faster than avg
Panel avg: 87d · This submission: 27d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LEG Device Classification - Class 2, Special Controls

Product Code LEG Enzyme Immunoassay, Valproic Acid
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.3645
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Toxicology devices follow this clearance model.

Regulatory Peers - LEG Enzyme Immunoassay, Valproic Acid

All 31
Devices cleared under the same product code (LEG) and FDA review panel - the closest regulatory comparables to K895569.
COBAS-FP REAGENT FOR VALPROIC ACID AND CALIBRATORS
K925003 · Roche Diagnostic Systems, Inc. · Dec 1992
BECKMAN VALPROIC ACID REAGENT
K922844 · Beckman Instruments, Inc. · Oct 1992
MODIFIED OPUS VALPROIC ACID TEST SYSTEM
K901538 · Pb Diagnostic Systems, Inc. · Jun 1990
COBAS-FP REAGENT FOR VALPROIC ACID & CALIBRATORS
K891581 · Roche Diagnostic Systems, Inc. · Aug 1989
EMIT VALPROIC ACID ASSAY
K862652 · Syva Co. · Jul 1986
EMIT AED VALPROIC ACID ASSAY
K832719 · Syva Co. · Oct 1983